Literature DB >> 15308272

Pharmacodynamics of antimicrobial drugs.

Matthew E Levison1.   

Abstract

Knowledge of the antimicrobial pharmacodynamic characteristics of a drug (inhibition of growth, rate and extent of bactericidal action, and postantibiotic effect) provides a more rational basis for determination of optimal dosing regimens in terms of the dose and the dosing interval. This article reviews concepts of antimicrobial pharmacodynamics, the effect of pharmacodynamics on the emergence of resistant bacterial subpopulations, and the development of pharmacodynamic breakpoints for use in the design of trials of these drugs and in treatment of infected patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308272     DOI: 10.1016/j.idc.2004.04.012

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  52 in total

1.  General principles of antimicrobial therapy.

Authors:  Surbhi Leekha; Christine L Terrell; Randall S Edson
Journal:  Mayo Clin Proc       Date:  2011-02       Impact factor: 7.616

2.  Lack of antimicrobial bactericidal activity in Mycobacterium abscessus.

Authors:  Florian P Maurer; Vera L Bruderer; Claudia Ritter; Claudio Castelberg; Guido V Bloemberg; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

3.  Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and children.

Authors:  Jesse DeLeon; Bruce E Silverstein; Catherine Allaire; Lynne S Gearinger; Kirk M Bateman; Timothy W Morris; Timothy L Comstock
Journal:  Clin Drug Investig       Date:  2012-05-01       Impact factor: 2.859

Review 4.  Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.

Authors:  Tiphaine Goulenok; Bruno Fantin
Journal:  Clin Pharmacokinet       Date:  2013-10       Impact factor: 6.447

5.  Azithromycin enhances phagocytic killing of Aggregatibacter actinomycetemcomitans Y4 by human neutrophils.

Authors:  Pin-Chuang Lai; Mark R Schibler; John D Walters
Journal:  J Periodontol       Date:  2015-01       Impact factor: 6.993

Review 6.  In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB.

Authors:  Pavan K Vaddady; Richard E Lee; Bernd Meibohm
Journal:  Future Med Chem       Date:  2010-08       Impact factor: 3.808

7.  Evaluation of the anti-candidal activity of methanolic leaf extract of cleistopholis patens (fam. Annonaceae) on candida species isolated from stage II HIV patients.

Authors:  David C Okechukwu; Mumuni A Momoh; Charles O Esimone
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

Review 8.  Beyond conventional antibiotics - New directions for combination products to combat biofilm.

Authors:  Danir Fanisovich Bayramov; Jennifer Ann Neff
Journal:  Adv Drug Deliv Rev       Date:  2016-08-03       Impact factor: 15.470

9.  Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.

Authors:  Ralph Gertler; Michael Gruber; Gunther Wiesner; Stanislas Grassin-Delyle; Saïk Urien; Peter Tassani-Prell; Klaus Martin
Journal:  Br J Clin Pharmacol       Date:  2018-06-15       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Authors:  Antonello Di Paolo; Giovanni Gori; Carlo Tascini; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.